References
- Sorger PK. Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms. An NIH White Paper by the QSP Workshop Group. 2011 October; www.nigms.nih.gov/training/documents/systemspharmawpsorger2011.pdf
- Stone JA, Banfield C, Pfister M, et al. Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industry. J Clin Pharmacol. 2010;50(9 Suppl):20S–30S.
- Pfister M, D’Argenio DZ. The emerging scientific discipline of pharmacometrics. J Clin Pharmacol. 2010;50(9 Suppl):6S.
- Mould DR, D’Haens G, Upton RN. Clinical decision support tools: the evolution of a revolution. Clin Pharmacol Ther. 2016;99(4):405–418.
- Tunc S, Alagoz O, Burnside E. Opportunities for operations research in medical decision making. IEEE Intell Syst. 2014;29(3):59–62.
- 438912037719000New horizons for health through mobile technologies. www.who.int/goe/publications/goe_mhealth_web.pdf
- Collaborative Health Research Projects. http://www.cihr-irsc.gc.ca/e/48042.html8
- Innovations in eHealth: empowering patients, enabling better health care. www.cihr-irsc.gc.ca/e/47342.html
- National research organization Mitacs in Canada. www.mitacs.ca/en/about-mitacs/annual-reports
- eHealth Innovations Priority Setting Workshop Summary Report. www.cihr-irsc.gc.ca/e/48625.html
- Romero K, Sinha V, Allerheiligen S, et al. Modeling and simulation for medical product development and evaluation: highlights from the FDA-C-path-ISOP 2013 workshop. J Pharmacokinet Pharmacodyn. 2014 Dec;41(6):545–552.
- Mobile Medical Applications. Guidance for Industry and Food and Drug Administration Staff Document issued on February 9. 2015 www.fda.gov/downloads/MedicalDevices/…/UCM263366.pdf
- Digital agenda for Europe. https://ec.europa.eu/digital-agenda/en/mhealth
- Technology Transfer at Univalor. www.univalor.ca/en/technology-transfer-univalor
- Hennig S, Standing JF, Staatz CE, et al. Population pharmacokinetics of tobramycin in patients with and without cystic fibrosis. Clin Pharmacokinet. 2013;52:289–301.
- Decision support tool DOSEME. https://doseme.com.au/
- Abdel-Rahman SM, Breitkreutz ML, Bi C, et al. Design and testing of an EHR-integrated, busulfan pharmacokinetic decision support tool for the point-of-care clinician. Front Pharmacol. 2016 Mar 30;(7):65. eCollection 2016. PMID: 27065859 Free PMC Article. DOI:10.3389/fphar.2016.00065
- Barbolosi D, Ciccolini J, Meille C, et al. Cancer metronomics chemotherapy: time for computational decision support. Chemother Pharmacol. 2014 Sep;74(3):647–652. Epub 2014 Aug 1. Review. PMID: 25082520. DOI:10.1007/s00280-014-2546-1
- Buclin T, Gotta V, Fuchs A, et al. Monitoring drug therapy. Br J Clin Pharmacol. 2012;73:917–923.
- Johnston LE, Grimm JC, Magruder JT, et al. Development of a transplantation risk index in patients with mechanical circulatory support: a decision support tool. JACC Heart Fail. 2016 Apr;4(4):277–286. Epub 2016 Feb 10. PMID: 26874393. DOI:10.1016/j.jchf.2015.11.009
- Quinn CC, Shardell MD, Terrin ML, et al. Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control. Diabetes Care. 2011;34.9:1934–1942.
- Tsoukalas A, Albertson T, Tagkopoulos I. From data to optimal decision making: a data-driven, probabilistic machine learning approach to decision support for patients with sepsis. JMIR Med Inform. 2015 Feb 24;3(1):e11. 3445.PMID: 25710907 Free PMC Article. DOI:10.2196/medinform
- Quinn CC, Clough SS, Minor JM, et al. WellDoc™ mobile diabetes management randomized controlled trial: change in clinical and behavioral outcomes and patient and physician satisfaction. Diabetes Technol Ther. 2008;10(3):160–168.
- Widmer N, Csajka C, Werner D, et al. Principles of therapeutic drug monitoring. Rev Med Suisse. 2008;4(165):1644-8, 1649-50, 1652-60.
- Schumacher GE, Barr JT. Economic and outcome issues for therapeutic drug monitoring in medicine. Ther Drug Monit. 1998;20:539–542.
- Fuchs A, Csajka C, Thoma Y, et al. Widmer. Benchmarking therapeutic drug monitoring software: a review of available computer tools. Clin Pharmacokinet. 2013;52(1):9–22.
- Roggero P, Giann ML, Orsi A, et al. Neonatal period: body composition changes in breast-fed full-term newborns. Neonatology. 2010;97(2):139–143.
- Macdonald P, Ross SR, Grant L, et al. Neonatal weight loss in breast and formula fed infants. Arch Dis Child Fetal Neonatal Ed. 2003;88(6):F472-6.
- Oddie SJ, Craven V, Deakin K, et al. Severe neonatal hypernatremia: a population based study. Arch Dis Child Fetal Neonatal Ed. 2013;98(5):F384-7.
- Yang WC, Zhao LL, Li YC, et al. Bodyweight loss in predicting neonatal hyperbilirubinemia 72 hours after birth in term newborn infants. BMC Pediatrics. 2013;13(1):1.
- Escobar GJ, Greene JD, Hulac P, et al. Rehospitalisation after birth hospitalisation: patterns among infants of all gestations. Arch Dis Child. 2005;90(2):125–131.
- Wilbaux M, Kasser S, Wellmann S, et al. Characterizing and forecasting individual weight changes in term neonates. J Pediatr. 2016;173:101–107.
- Taichman DB, Backus J, Baethge C, et al. Sharing clinical trial data: a proposal from the international committee of medical journal editors. Jama. 2016;315(5):467–468.
- Wagner-Menghin M, Pokieser P. Information technology and social sciences: how can health IT be used to support the health professional?. Ann N Y Acad Sci. 2016;1381(1):152–161.
- Wilhide IIICC, Peeples MM, Anthony Kouyaté RC. Evidence-based mhealth chronic disease mobile app intervention design: development of a framework. JMIR Res Protoc. 2016;5(1):e25.